Three drugmakers recently announced refunds for 340B covered entities that were overcharged when buying certain drugs. Viatris, Amgen and GSK [...] …
Category: Regulatory
Breaking News
Federal Judge Upholds HHS’ Right to Pre-Approve 340B Rebates, Tosses Four of Five Drugmaker Lawsuits
A federal district judge has upheld the federal government’s authority to require agency approval of drugmaker 340B rebate models, dealing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. provided his first public remarks on the 340B program Wednesday [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four major drugmakers and an industry vendor are urging a federal judge not to delay ruling on their 340B rebate [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal appeals court judges on Friday questioned whether four major insulin manufacturers could have imposed similar 340B contract pharmacy restrictions [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A key national hospital advocacy group recently urged the Trump administration to modify the retrospective payment process under the Inflation [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. Department of Health and Human Services (HHS) plans to release guidance within 30 days on 340B rebate models [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge today in Washington, D.C. scrutinized arguments from both manufacturers and the government in a closely watched hearing [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A federal judge in Washington, D.C., is holding high-stakes hearings today on five drug industry lawsuits challenging the government’s opposition [...] …